Detalles de la búsqueda
1.
Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
J Infect Dis
; 226(3): 431-440, 2022 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584386
2.
Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for hepatitis C virus infection.
J Gastroenterol Hepatol
; 37(2): 371-377, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618379
3.
Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals.
J Gastroenterol Hepatol
; 37(1): 190-199, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34374128
4.
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.
Liver Int
; 40(7): 1578-1589, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32304611
5.
Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis.
Hepatol Res
; 50(2): 174-181, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634412
6.
Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study.
Hepatol Res
; 49(6): 617-626, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30849206
7.
Immunoserological and histological differences between autoimmune hepatitis with acute presentation and chronic autoimmune hepatitis.
Hepatol Res
; 47(13): 1375-1382, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28219122
8.
Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis.
Hepatol Res
; 47(3): E120-E131, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27142311
9.
Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C.
Hepatol Res
; 46(3): E174-80, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26189962
10.
Severe Ulcerative Skin Lesions Due to Lenvatinib.
Clin Gastroenterol Hepatol
; 18(10): e113, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31100461
11.
Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.
J Gastroenterol Hepatol
; 30(12): 1759-67, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26095167
12.
Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C.
J Gastroenterol Hepatol
; 30(8): 1309-16, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25777545
13.
[A case of drug-induced liver injury caused by Keishi-karyukotsu-boreito and Shin-i-seihaito].
Nihon Shokakibyo Gakkai Zasshi
; 112(6): 1054-9, 2015 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-26050729
14.
Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.
J Gastroenterol Hepatol
; 29(9): 1728-35, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24731162
15.
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study.
J Hepatol
; 58(3): 495-501, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23099187
16.
Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy.
J Hepatol
; 59(4): 667-74, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23707372
17.
Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.
J Hepatol
; 59(2): 205-12, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23542346
18.
The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.
Hepatogastroenterology
; 60(128): 2034-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24719946
19.
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis.
Fukuoka Igaku Zasshi
; 104(10): 350-61, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24511666
20.
Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
J Gastroenterol Hepatol
; 27(7): 1233-40, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22098185